Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1JOURNAL OF IMMUNOLOGYIF3.42019-02-015OAAI
Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral InhibitionJOURNAL OF IMMUNOLOGY RESEARCHIF3.62016-01-017OAAI
Impact of IgA Constant Domain on HIV-1 Neutralizing Function of Monoclonal Antibody F425A1g8JOURNAL OF IMMUNOLOGYIF3.42013-01-0123OAAI
Enhanced Neutralization of HIV by Antibodies Displayed on the S-Layer of Caulobacter crescentusANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52011-12-0114OAAI
A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophilsJOURNAL OF VIROLOGYIF3.82008-05-0178OAAI
The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domainJOURNAL OF IMMUNOLOGYIF3.42007-06-0136OAAI
Dichotomy in cross-clade reactivity and neutralization by HIV-1 sera: Implications for active and passive immunotherapyJOURNAL OF MEDICAL VIROLOGYIF4.62005-04-153OA
Conformational changes in env oligomer induced by an antibody dependent on the V3 loop baseAIDSIF3.12003-03-0154OAAI
Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virionsAIDSIF3.12002-12-0151OAAI
Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individualsJOURNAL OF VIROLOGYIF3.81999-11-0120OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向